Tag: SARSCoV2

Browse exclusive Tags!

COVID-19 Leaves Lasting Lung Damage in Indian Population, Study Finds

Study finds lasting lung damage post-COVID in Indian population. Indians show more lung impairment compared to Europeans and Chinese.

Doctors Recommend Precautionary Booster Doses as New Covid-19 Sub-Variant Emerges, India

Doctors urge precautionary booster doses as new Covid-19 sub-variant emerges. Stay protected against evolving virus and enhance immune response.

COVID-19’s Lingering Impact on the Brain: A Startling Discovery

COVID-19's impact on the brain: Startling study reveals long-term effects & brain cell fusion. Learn more in this eye-opening article.

Japanese Scientists Find Covid and Variants are Laboratory Creations – Disturbing Revelations Spark Controversy

Disturbing revelations suggest that COVID-19 and its variants are laboratory creations. A recent study uncovers dangerous implications of producing viruses designed to infect humans.

Popular

SARS-CoV-2 Still Active: Novel Drug Under Clinical Trials Emerges as the Safest Treatment Option for COVID-19 Cases Worldwide

Discover NV-CoV-2: A novel nanomedicine drug with broad-spectrum anti-coronavirus properties, promising safety, and efficacy in clinical trials. Will it be the answer to COVID-19?

New Omicron Subvariant XBB Shows Weakened Pathogenicity with Key Mutations: Study

New study reveals weakened pathogenicity of Omicron subvariant XBB, offering hope in the fight against COVID-19. Explore the key mutations and their implications here.

Israeli Study Reveals Overlapping Properties Between SARS-CoV-2 Viral Proteins and Human Gut Antigens

New Israeli study explores link between SARS-CoV-2 and gut autoimmune diseases, shedding light on the potential implications for COVID-19.

Butyrate: A Promising Preventive Measure Against SARS-CoV-2, Boosting Antiviral Immune Responses and Cell Survival

Discover the potential of butyrate as a preventive measure against SARS-CoV-2. Boost antiviral immune responses and cell survival with butyrate. Learn more here.

Subscribe

spot_imgspot_img